Cigarette smoking and colorectal cancer: From epidemiology to bench

Journal of Experimental and Clinical Medicine

Volumn 3, Issue 6, 2011, Pages 257-261

  Wei, Po Li ^a,b   Lin, Shyr Yi ^b,c   Chang, Yu Jia ^a,c  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

4 (methylnitrosamino) 1 (3 pyridyl) 1 butanone (NNK); Colorectal cancer; Nicotine; Nicotinic acetylcholine receptor; Smoking

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; B RAF KINASE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BUNGAROTOXIN RECEPTOR; CARCINOGEN; CYCLOOXYGENASE 2; FIBRONECTIN; GELATINASE A; GELATINASE B; NICOTINE; VASCULOTROPIN;

ABERRANT CRYPT FOCUS; ADVANCED CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CIGARETTE SMOKING; COLON POLYPOSIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; GENE MUTATION; HUMAN; MICROSATELLITE INSTABILITY; NONHUMAN; ONCOGENE K RAS; PASSIVE SMOKING; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RECTUM POLYP; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION;

EID: 83555179722     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2011.10.002     Document Type: Review

References (64)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
3. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
4. Limsui D., Limburg P.J. Cigarette smoking and colorectal cancer risk: a burning issue. Gastroenterology 2008, 135:704-705.
5. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003, 3:733-744.
6. Chen R.J., Ho Y.S., Wu C.H., Wang Y.J. Molecular mechanisms of nicotine-induced bladder cancer. J Exp Clin Med 2011, 3:252-256.
7. Ho Y.S., Lee C.H., Wu C.H. a9-nicotinic acetylcholine receptor serves as a molecular target for breast cancer therapy. J Exp Clin Med 2011, 3:246-251.
8. Hung C.S., Peng Y.J., Wei P.L., Lee C.H., Ho Y.S., Wu C.H., Chang Y.J. The Alpha9 nicotinic acetylcholine receptor is the key mediator in nicotine-enhanced cancer metastasis in breast cancer cells. J Exp Clin Med 2011, 3:283-292.
9. Lai C.S., Pan M.H. Chemopreventive effects of natural dietary compounds on smoking-induced tumorigenesis. J Exp Clin Med 2011, 3:262-271.
10. Yamasaki E., Ames B.N. Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine. Proc Natl Acad Sci USA 1977, 74:3555-3559.
11. Kune G.A., Kune S., Vitetta L., Watson L.F. Smoking and colorectal cancer risk: data from the melbourne colorectal cancer study and brief review of literature. Int J Cancer 1992, 50:369-372.
12. Liang P.S., Chen T.Y., Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 2009, 124:2406-2415.
13. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001, 10:725-731.
14. Lieberman D.A., Prindiville S., Weiss D.G., Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. Jama 2003, 290:2959-2967.
15. Toyomura K., Yamaguchi K., Kawamoto H., Tabata S., Shimizu E., Mineshita M., Ogawa S., et al. Relation of cigarette smoking and alcohol use to colorectal adenomas by subsite: the self-defense forces health study. Cancer Sci 2004, 95:72-76.
16. Moslehi R., Chatterjee N., Church T.R., Chen J., Yeager M., Weissfeld J., Hein D.W., et al. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma. Pharmacogenomics 2006, 7:819-829.
17. Anderson J.C., Attam R., Alpern Z., Messina C.R., Hubbard P., Grimson R., Ells P.F., et al. Prevalence of colorectal neoplasia in smokers. Am J Gastroenterol 2003, 98:2777-2783.
18. Tiemersma E.W., Bunschoten A., Kok F.J., Glatt H., de Boer S.Y., Kampman E. Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas. Int J Cancer 2004, 108:97-103.
19. Omata F., Brown W.R., Tokuda Y., Takahashi O., Fukui T., Ueno F., Mine T. Modifiable risk factors for colorectal neoplasms and hyperplastic polyps. Intern Med 2009, 48:123-128.
20. Saebo M., Skjelbred C.F., Brekke Li K., Bowitz Lothe I.M., Hagen P.C., Johnsen E., Tveit K.M., et al. CYP1A2 164 A→C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas. Anticancer Res 2008, 28:2289-2295.
21. Botteri E., Iodice S., Raimondi S., Maisonneuve P., Lowenfels A.B. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 2008, 134:388-395.
22. Shrubsole M.J., Wu H., Ness R.M., Shyr Y., Smalley W.E., Zheng W. Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 2008, 167:1050-1058.
23. Ji B.T., Weissfeld J.L., Chow W.H., Huang W.Y., Schoen R.E., Hayes R.B. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2006, 15:897-901.
24. Paskett E.D., Reeves K.W., Pineau B., Albert P.S., Caan B., Hasson M., Iber F., et al. The association between cigarette smoking and colorectal polyp recurrence (United States). Cancer Causes Control 2005, 16:1021-1033.
25. Larsen I.K., Grotmol T., Almendingen K., Hoff G. Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol 2006, 6:5.
26. Moxon D., Raza M., Kenney R., Ewing R., Arozullah A., Mason J.B., Carroll R.E. Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population. Clin Gastroenterol Hepatol 2005, 3:271-278.
27. Mutch M.G., Schoen R.E., Fleshman J.W., Rall C.J., Dry S., Seligson D., Charabaty A., et al. A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol 2009, 7:568-574.
28. Terry P., Ekbom A., Lichtenstein P., Feychting M., Wolk A. Long-term tobacco smoking and colorectal cancer in a prospective cohort study. Int J Cancer 2001, 91:585-587.
29. Terry P.D., Miller A.B., Rohan T.E. Prospective cohort study of cigarette smoking and colorectal cancer risk in women. Int J Cancer 2002, 99:480-483.
30. Paskett E.D., Reeves K.W., Rohan T.E., Allison M.A., Williams C.D., Messina C.R., Whitlock E., et al. Association between cigarette smoking and colorectal cancer in the Women's Health Initiative. J Natl Cancer Inst 2007, 99:1729-1735.
31. Sharpe C.R., Siemiatycki J.A., Rachet B.P. The effects of smoking on the risk of colorectal cancer. Dis Colon Rectum 2002, 45:1041-1050.
32. Akhter M., Nishino Y., Nakaya N., Kurashima K., Sato Y., Kuriyama S., Tsubono Y., et al. Cigarette smoking and the risk of colorectal cancer among men: a prospective study in Japan. Eur J Cancer Prev 2007, 16:102-107.
33. Verla-Tebit E., Lilla C., Hoffmeister M., Brenner H., Chang-Claude J. Cigarette smoking and colorectal cancer risk in Germany: a population-based case-control study. Int J Cancer 2006, 119:630-635.
34. Gram I.T., Braaten T., Lund E., Le Marchand L., Weiderpass E. Cigarette smoking and risk of colorectal cancer among Norwegian women. Cancer Causes Control 2009, 20:895-903.
35. Ho J.W., Lam T.H., Tse C.W., Chiu L.K., Lam H.S., Leung P.F., Ng K.C., et al. Smoking, drinking and colorectal cancer in Hong Kong Chinese: a case-control study. Int J Cancer 2004, 109:587-597.
36. Tsoi K.K., Pau C.Y., Wu W.K., Chan F.K., Griffiths S., Sung J.J. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2009, 7:682-688.
37. Botteri E., Iodice S., Bagnardi V., Raimondi S., Lowenfels A.B., Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. Jama 2008, 300:2765-2778.
38. Acott A.A., Theus S.A., Marchant-Miros K.E., Mancino A.T. Association of tobacco and alcohol use with earlier development of colorectal cancer: should we modify screening guidelines?. Am J Surg 2008, 196:915-918. discussion 918-9.
39. Zisman A.L., Nickolov A., Brand R.E., Gorchow A., Roy H.K. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med 2006, 166:629-634.
40. Buc E., Kwiatkowski F., Alves A., Panis Y., Mantion G., Slim K. Tobacco smoking: a factor of early onset of colorectal cancer. Dis Colon Rectum 2006, 49:1893-1896.
41. Peppone L.J., Mahoney M.C., Cummings K.M., Michalek A.M., Reid M.E., Moysich K.B., Hyland A. Colorectal cancer occurs earlier in those exposed to tobacco smoke: implications for screening. J Cancer Res Clin Oncol 2008, 134:743-751.
42. Colangelo L.A., Gapstur S.M., Gann P.H., Dyer A.R. Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer 2004, 100:288-293.
43. Kenfield S.A., Stampfer M.J., Rosner B.A., Colditz G.A. Smoking and smoking cessation in relation to mortality in women. Jama 2008, 299:2037-2047.
44. Luchtenborg M., Weijenberg M.P., Kampman E., van Muijen G.N., Roemen G.M., Zeegers M.P., Goldbohm R.A., et al. Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. Am J Epidemiol 2005, 161:806-815.
45. Sarebo M., Skjelbred C.F., Breistein R., Lothe I.M., Hagen P.C., Bock G., Hansteen I.L., et al. Association between cigarette smoking, APC mutations and the risk of developing sporadic colorectal adenomas and carcinomas. BMC Cancer 2006, 6:71.
46. Wark P.A., Van der Kuil W., Ploemacher J., Van Muijen G.N., Mulder C.J., Weijenberg M.P., Kok F.J., et al. Diet, lifestyle and risk of K-ras mutation-positive and -negative colorectal adenomas. Int J Cancer 2006, 119:398-405.
47. Weijenberg M.P., Aardening P.W., de Kok T.M., de Goeij A.F., van den Brandt P.A. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study. Mutat Res 2008, 652:54-64.
48. Porta M., Crous-Bou M., Wark P.A., Vineis P., Real F.X., Malats N., Kampman E. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes. Mutat Res 2009, 682:83-93.
49. Curtin K., Samowitz W.S., Wolff R.K., Herrick J., Caan B.J., Slattery M.L. Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer 2009, 125:158-164.
50. Samowitz W.S., Albertsen H., Sweeney C., Herrick J., Caan B.J., Anderson K.E., Wolff R.K., et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 2006, 98:1731-1738.
51. Chia V.M., Newcomb P.A., Bigler J., Morimoto L.M., Thibodeau S.N., Potter J.D. Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use. Cancer Res 2006, 66:6877-6883.
52. Slattery M.L., Curtin K., Anderson K., Ma K.N., Ballard L., Edwards S., Schaffer D., et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000, 92:1831-1836.
53. Ye Y.N., Wu W.K., Shin V.Y., Cho C.H. A mechanistic study of colon cancer growth promoted by cigarette smoke extract. Eur J Pharmacol 2005, 519:52-57.
54. Ye Y.N., Liu E.S., Shin V.Y., Wu W.K., Luo J.C., Cho C.H. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther 2004, 308:66-72.
55. Wong H.P., Yu L., Lam E.K., Tai E.K., Wu W.K., Cho C.H. Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol Appl Pharmacol 2007, 221:261-267.
56. Wei P.L., Kuo L.J., Huang M.T., Ting W.C., Ho Y.S., Wang W., An J., et al. Nicotine enhances colon cancer cell migration by induction of fibronectin. Ann Surg Oncol 2011, 18:1782-1790.
57. Wong H.P., Yu L., Lam E.K., Tai E.K., Wu W.K., Cho C.H. Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 2007, 97:279-287.
58. Schuller H.M., Orloff M. Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem Pharmacol 1998, 55:1377-1384.
59. Kim M., Miyamoto S., Sugie S., Yasui Y., Ishigamori-Suzuki R., Murakami A., Nakagama H., et al. A tobacco-specific carcinogen, NNK, enhances AOM/DSS-induced colon carcinogenesis in male A/J mice. In Vivo 2008, 22:557-563.
60. Ye Y.N., Liu E.S., Shin V.Y., Wu W.K., Cho C.H. The modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. J Pharmacol Exp Ther 2004, 311:123-130.
61. Wu W.K., Wong H.P., Luo S.W., Chan K., Huang F.Y., Hui M.K., Lam E.K., et al. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via beta-adrenoceptors. Cancer Res 2005, 65:5272-5277.
62. Wei P.L., Chang Y.J., Ho Y.S., Lee C.H., Yang Y.Y., An J., Lin S.Y. Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor. Ann Surg 2009, 249:978-985.
63. Natori T., Sata M., Washida M., Hirata Y., Nagai R., Makuuchi M. Nicotine enhances neovascularization and promotes tumor growth. Mol Cells 2003, 16:143-146.
64. Schuller H.M. Nitrosamines as nicotinic receptor ligands. Life Sci 2007, 80:2274-2280.